nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—Levothyroxine—hypothyroidism	0.225	0.336	CbGbCtD
Flupentixol—ABCB1—Liothyronine—hypothyroidism	0.225	0.336	CbGbCtD
Flupentixol—ABCB1—Liotrix—hypothyroidism	0.22	0.328	CbGbCtD
Flupentixol—DDC—Amine-derived hormones—IYD—hypothyroidism	0.0362	0.208	CbGpPWpGaD
Flupentixol—DDC—Amine-derived hormones—TPO—hypothyroidism	0.029	0.166	CbGpPWpGaD
Flupentixol—DDC—nerve—hypothyroidism	0.0221	0.142	CbGeAlD
Flupentixol—HTR2A—cerebellar cortex—hypothyroidism	0.0173	0.111	CbGeAlD
Flupentixol—DRD1—nerve—hypothyroidism	0.0162	0.105	CbGeAlD
Flupentixol—DDC—Amine-derived hormones—TSHB—hypothyroidism	0.0134	0.0769	CbGpPWpGaD
Flupentixol—DDC—Amine-derived hormones—SLC5A5—hypothyroidism	0.01	0.0575	CbGpPWpGaD
Flupentixol—DRD2—nerve—hypothyroidism	0.0096	0.0618	CbGeAlD
Flupentixol—HTR2A—urine—hypothyroidism	0.00917	0.059	CbGeAlD
Flupentixol—HTR2A—nerve—hypothyroidism	0.00633	0.0407	CbGeAlD
Flupentixol—DDC—adrenal gland—hypothyroidism	0.00613	0.0394	CbGeAlD
Flupentixol—DDC—testis—hypothyroidism	0.00507	0.0326	CbGeAlD
Flupentixol—DDC—Amino acid and derivative metabolism—IYD—hypothyroidism	0.00505	0.0289	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00498	0.0286	CbGpPWpGaD
Flupentixol—DDC—liver—hypothyroidism	0.00479	0.0308	CbGeAlD
Flupentixol—CHRM1—cardiovascular system—hypothyroidism	0.00417	0.0269	CbGeAlD
Flupentixol—DDC—Amino acid and derivative metabolism—TPO—hypothyroidism	0.00404	0.0231	CbGpPWpGaD
Flupentixol—ADRA1A—heart—hypothyroidism	0.00363	0.0234	CbGeAlD
Flupentixol—ADRA1A—cardiovascular system—hypothyroidism	0.00343	0.0221	CbGeAlD
Flupentixol—DDC—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00321	0.0184	CbGpPWpGaD
Flupentixol—DRD2—pituitary gland—hypothyroidism	0.00298	0.0192	CbGeAlD
Flupentixol—DDC—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00275	0.0157	CbGpPWpGaD
Flupentixol—ADRA1A—adrenal gland—hypothyroidism	0.00271	0.0175	CbGeAlD
Flupentixol—ADRA1A—blood—hypothyroidism	0.00271	0.0175	CbGeAlD
Flupentixol—HTR2A—heart—hypothyroidism	0.00235	0.0151	CbGeAlD
Flupentixol—HTR2A—cardiovascular system—hypothyroidism	0.00222	0.0143	CbGeAlD
Flupentixol—DRD2—testis—hypothyroidism	0.0022	0.0142	CbGeAlD
Flupentixol—ADRA1A—liver—hypothyroidism	0.00212	0.0137	CbGeAlD
Flupentixol—ADRA1A—cerebellum—hypothyroidism	0.00207	0.0133	CbGeAlD
Flupentixol—DRD2—cerebellum—hypothyroidism	0.00203	0.0131	CbGeAlD
Flupentixol—HTR2A—gonad—hypothyroidism	0.00201	0.013	CbGeAlD
Flupentixol—HTR2A—pituitary gland—hypothyroidism	0.00196	0.0126	CbGeAlD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00193	0.0111	CbGpPWpGaD
Flupentixol—DDC—Amino acid and derivative metabolism—TSHB—hypothyroidism	0.00187	0.0107	CbGpPWpGaD
Flupentixol—HTR2A—adrenal gland—hypothyroidism	0.00175	0.0113	CbGeAlD
Flupentixol—HTR2A—blood—hypothyroidism	0.00175	0.0113	CbGeAlD
Flupentixol—ABCB1—adrenal cortex—hypothyroidism	0.00159	0.0102	CbGeAlD
Flupentixol—ABCB1—heart—hypothyroidism	0.00154	0.00991	CbGeAlD
Flupentixol—ABCB1—cardiovascular system—hypothyroidism	0.00145	0.00935	CbGeAlD
Flupentixol—HTR2A—testis—hypothyroidism	0.00145	0.00934	CbGeAlD
Flupentixol—DRD1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00144	0.00822	CbGpPWpGaD
Flupentixol—DDC—Amino acid and derivative metabolism—SLC5A5—hypothyroidism	0.0014	0.00801	CbGpPWpGaD
Flupentixol—HTR2A—liver—hypothyroidism	0.00137	0.00883	CbGeAlD
Flupentixol—DRD1—G alpha (s) signalling events—TSHB—hypothyroidism	0.00136	0.0078	CbGpPWpGaD
Flupentixol—DRD1—G alpha (s) signalling events—TSHR—hypothyroidism	0.00136	0.0078	CbGpPWpGaD
Flupentixol—HTR2A—cerebellum—hypothyroidism	0.00134	0.00862	CbGeAlD
Flupentixol—ABCB1—gonad—hypothyroidism	0.00132	0.00849	CbGeAlD
Flupentixol—ABCB1—pituitary gland—hypothyroidism	0.00129	0.00828	CbGeAlD
Flupentixol—DDC—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00128	0.00733	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00125	0.00714	CbGpPWpGaD
Flupentixol—ABCB1—adrenal gland—hypothyroidism	0.00115	0.0074	CbGeAlD
Flupentixol—ABCB1—blood—hypothyroidism	0.00115	0.0074	CbGeAlD
Flupentixol—ABCB1—thyroid gland—hypothyroidism	0.00111	0.00714	CbGeAlD
Flupentixol—DRD2—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00108	0.00621	CbGpPWpGaD
Flupentixol—ABCB1—female gonad—hypothyroidism	0.00107	0.0069	CbGeAlD
Flupentixol—CHRM1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00106	0.00608	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—AVP—hypothyroidism	0.00104	0.00598	CbGpPWpGaD
Flupentixol—ABCB1—testis—hypothyroidism	0.00095	0.00612	CbGeAlD
Flupentixol—DDC—Metabolism—IYD—hypothyroidism	0.000927	0.00531	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (12/13) signalling events—VAV3—hypothyroidism	0.000905	0.00519	CbGpPWpGaD
Flupentixol—ABCB1—liver—hypothyroidism	0.000899	0.00578	CbGeAlD
Flupentixol—ABCB1—cerebellum—hypothyroidism	0.000878	0.00565	CbGeAlD
Flupentixol—HTR2A—G alpha (q) signalling events—TRH—hypothyroidism	0.000817	0.00468	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.000812	0.00465	CbGpPWpGaD
Flupentixol—DRD1—G alpha (s) signalling events—AVP—hypothyroidism	0.000802	0.0046	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—TRH—hypothyroidism	0.0008	0.00458	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ATP5O—hypothyroidism	0.000788	0.00452	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000774	0.00443	CbGpPWpGaD
Flupentixol—DDC—Metabolism—TPO—hypothyroidism	0.000741	0.00425	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00073	0.00418	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000728	0.00417	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000726	0.00416	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000715	0.0041	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000649	0.00372	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000649	0.00372	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—TRH—hypothyroidism	0.000554	0.00318	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00055	0.00315	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—AVP—hypothyroidism	0.000545	0.00312	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000541	0.0031	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000538	0.00308	CbGpPWpGaD
Flupentixol—DRD1—G alpha (s) signalling events—POMC—hypothyroidism	0.000533	0.00305	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00053	0.00303	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000496	0.00284	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—TSHR—hypothyroidism	0.000494	0.00283	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—TSHB—hypothyroidism	0.000494	0.00283	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00049	0.00281	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00049	0.00281	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000482	0.00276	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000482	0.00276	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000479	0.00275	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000479	0.00275	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000472	0.0027	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000472	0.0027	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—AVP—hypothyroidism	0.000429	0.00246	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	0.000427	0.00244	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	0.00042	0.00241	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—TRH—hypothyroidism	0.000419	0.0024	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—TRH—hypothyroidism	0.000412	0.00236	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—AVP—hypothyroidism	0.000411	0.00236	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—TRH—hypothyroidism	0.00041	0.00235	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	0.000403	0.00231	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	0.000403	0.00231	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000384	0.0022	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000382	0.00219	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000382	0.00219	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000376	0.00215	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—TSHR—hypothyroidism	0.000373	0.00214	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—TSHB—hypothyroidism	0.000373	0.00214	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	0.000367	0.0021	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	0.000367	0.0021	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000365	0.00209	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000365	0.00209	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	0.000359	0.00206	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	0.000359	0.00206	CbGpPWpGaD
Flupentixol—DDC—Metabolism—TSHB—hypothyroidism	0.000343	0.00197	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000335	0.00192	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—TRH—hypothyroidism	0.000313	0.00179	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PIK3C2A—hypothyroidism	0.000306	0.00175	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—AVP—hypothyroidism	0.000291	0.00167	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000289	0.00165	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—TRH—hypothyroidism	0.000284	0.00163	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000284	0.00163	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000283	0.00162	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—TSHB—hypothyroidism	0.000279	0.0016	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—TSHR—hypothyroidism	0.000279	0.0016	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000278	0.00159	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000277	0.00159	CbGpPWpGaD
Flupentixol—DDC—Metabolism—SLC5A5—hypothyroidism	0.000257	0.00147	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000254	0.00146	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—TSHR—hypothyroidism	0.000254	0.00145	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—TSHB—hypothyroidism	0.000254	0.00145	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	0.000241	0.00138	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—TRH—hypothyroidism	0.000237	0.00136	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	0.000233	0.00133	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000231	0.00133	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	0.000228	0.00131	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—IYD—hypothyroidism	0.000226	0.0013	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—AVP—hypothyroidism	0.00022	0.00126	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—AVP—hypothyroidism	0.000216	0.00124	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000215	0.00123	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—TRH—hypothyroidism	0.000215	0.00123	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	0.000212	0.00121	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—TRH—hypothyroidism	0.000211	0.00121	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	0.000211	0.00121	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	0.000211	0.00121	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.00021	0.0012	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000207	0.00119	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000207	0.00119	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	0.000207	0.00119	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000206	0.00118	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000206	0.00118	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000203	0.00116	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000203	0.00116	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CLTC—hypothyroidism	0.000194	0.00111	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—POMC—hypothyroidism	0.000194	0.00111	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ATP5O—hypothyroidism	0.000192	0.0011	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000192	0.0011	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—TSHB—hypothyroidism	0.000191	0.0011	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—TSHR—hypothyroidism	0.000191	0.0011	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000189	0.00108	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.000188	0.00108	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.000188	0.00108	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000188	0.00108	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000187	0.00107	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000187	0.00107	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000185	0.00106	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	0.000184	0.00106	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	0.000184	0.00106	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TPO—hypothyroidism	0.000181	0.00104	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	0.000171	0.000979	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00017	0.000972	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TRH—hypothyroidism	0.000168	0.000963	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AVP—hypothyroidism	0.000165	0.000943	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—VAV3—hypothyroidism	0.000155	0.000889	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TSHR—hypothyroidism	0.00015	0.000858	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TSHB—hypothyroidism	0.00015	0.000858	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AVP—hypothyroidism	0.000149	0.000856	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CLTC—hypothyroidism	0.000147	0.000841	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—POMC—hypothyroidism	0.000146	0.000837	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CLTC—hypothyroidism	0.000144	0.000828	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—POMC—hypothyroidism	0.000144	0.000824	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CLTC—hypothyroidism	0.000144	0.000823	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—POMC—hypothyroidism	0.000143	0.000819	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	0.000141	0.00081	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	0.000141	0.000807	CbGpPWpGaD
Flupentixol—DDC—Metabolism—POMC—hypothyroidism	0.000134	0.00077	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000134	0.000767	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SH2B3—hypothyroidism	0.000134	0.000765	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	0.000129	0.000739	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000127	0.000727	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TRH—hypothyroidism	0.000127	0.000727	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	0.000126	0.000723	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TRH—hypothyroidism	0.000125	0.000715	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AVP—hypothyroidism	0.000124	0.000712	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000124	0.000712	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TRH—hypothyroidism	0.000124	0.000711	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	0.000122	0.0007	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TRH—hypothyroidism	0.000122	0.0007	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	0.000122	0.000697	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	0.00012	0.000686	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—VAV3—hypothyroidism	0.000117	0.000671	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	0.000115	0.00066	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	0.000115	0.000657	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TSHB—hypothyroidism	0.000113	0.000648	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TSHR—hypothyroidism	0.000113	0.000648	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AVP—hypothyroidism	0.000113	0.000646	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	0.000113	0.000646	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TSHB—hypothyroidism	0.000111	0.000638	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TSHR—hypothyroidism	0.000111	0.000638	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AVP—hypothyroidism	0.000111	0.000636	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TSHR—hypothyroidism	0.000111	0.000634	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TSHB—hypothyroidism	0.000111	0.000634	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AVP—hypothyroidism	0.00011	0.000633	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—POMC—hypothyroidism	0.000109	0.000627	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	0.000109	0.000624	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	0.000109	0.000624	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	0.000109	0.000623	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000105	0.000604	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SH2B3—hypothyroidism	0.000101	0.000578	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—POMC—hypothyroidism	9.93e-05	0.000569	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	9.92e-05	0.000568	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PRL—hypothyroidism	9.9e-05	0.000568	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	9.87e-05	0.000565	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	9.71e-05	0.000556	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VAV3—hypothyroidism	9.16e-05	0.000525	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AVP—hypothyroidism	8.83e-05	0.000506	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TSHB—hypothyroidism	8.37e-05	0.00048	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—POMC—hypothyroidism	8.26e-05	0.000473	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	8.12e-05	0.000465	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	8.08e-05	0.000463	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	7.96e-05	0.000456	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—POMC—hypothyroidism	7.5e-05	0.00043	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PRL—hypothyroidism	7.48e-05	0.000428	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3C2A—hypothyroidism	7.46e-05	0.000428	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—POMC—hypothyroidism	7.38e-05	0.000423	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PRL—hypothyroidism	7.36e-05	0.000422	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—POMC—hypothyroidism	7.34e-05	0.00042	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PRL—hypothyroidism	7.32e-05	0.000419	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	7.22e-05	0.000414	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PRL—hypothyroidism	7.2e-05	0.000413	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VAV3—hypothyroidism	6.92e-05	0.000396	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VAV3—hypothyroidism	6.81e-05	0.00039	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VAV3—hypothyroidism	6.77e-05	0.000388	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	6.67e-05	0.000382	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AVP—hypothyroidism	6.67e-05	0.000382	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AVP—hypothyroidism	6.56e-05	0.000376	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AVP—hypothyroidism	6.52e-05	0.000374	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AVP—hypothyroidism	6.42e-05	0.000368	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SLC5A5—hypothyroidism	6.27e-05	0.000359	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—POMC—hypothyroidism	5.87e-05	0.000336	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IGF1—hypothyroidism	5.64e-05	0.000323	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—POMC—hypothyroidism	4.43e-05	0.000254	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—POMC—hypothyroidism	4.36e-05	0.00025	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—POMC—hypothyroidism	4.33e-05	0.000248	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—POMC—hypothyroidism	4.27e-05	0.000245	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF1—hypothyroidism	4.26e-05	0.000244	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF1—hypothyroidism	4.19e-05	0.00024	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF1—hypothyroidism	4.17e-05	0.000239	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	4.1e-05	0.000235	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—POMC—hypothyroidism	3.28e-05	0.000188	CbGpPWpGaD
